AugSept Combined - Compressed
AugSept Combined - Compressed
AugSept Combined - Compressed
88 Addendum
EDITOR
Kevin J. Hanley, D.D.S.
MANAGING EDITOR
Mary Grates Stoll
ADVERTISING MANAGER
Jeanne DeGuire
ART DIRECTORS
Kathryn Sikule / Ed Stevens
tance of good dental health to the overall well-being of the individual. We have the Stanley M. Kerpel, D.D.S.
Elliott M. Moskowitz, D.D.S., M.Sd
science to demonstrate this link; we have to do a better job of conveying it to the
Francis J. Murphy, D.D.S.
public at large. Eugene A. Pantera Jr., D.D.S.
Cost is a large impediment to adults seeking care. We need to ask ourselves if Robert M. Peskin, D.D.S.
there are ways to reduce costs so that the patient is served well and properly and Georgios Romanos, D.D.S.,
D.M.D., Ph.D., Prof.Dr.med.dent
the dentist is able to maintain a good standard of living. We all know how difficult
Robert E. Schifferle, D.D.S., MMSc., Ph.D.
it is to run a practice in todays economy. Can we run our practices more effi-
ciently, or are there ways to economize so that savings can be made that can be PRINTER
passed on to our patients? Are reimbursement rates from insurance companies a
Fort Orange Press, Albany
stumbling block to a profitable dental practice? Do traditional delivery systems
constitute the most efficient way to deliver good dental care to our patients, or are NYSDJ (ISSN 0028-7571) is published six times a year,
in January, March, April, June/July, August/September
there alternative systems that would do the job better? These are all difficult ques-
and November, by the New York State Dental Association,
tions that need answers if dentistry is to survive as a profession. 20 Corporate Woods Boulevard, Suite 602, Albany, NY
12211. In February, May, October and December, sub-
Dentistry is at a crossroad. The road we take will dictate what dentistry will
scribers receive the NYSDA News. Periodicals postage
look like in the future. We deliver the best oral health care in the world. We need paid at Albany, NY. Subscription rates $25 per year to
to find innovative ways to finance and deliver cost-effective care to more people the members of the New York State Dental Association;
rates for nonmembers: $75 per year or $12 per issue,
more efficiently. At the same time, we must instill in the general population the U.S. and Canada; $135 per year foreign or $22 per issue.
idea that dentistry is important to their health and well-being. Postmaster: Please send change of address to the New
York State Dental Association, Suite 602, 20 Corporate
Changes are coming. It is inevitable. Nothing stays the same. If you remain Woods Boulevard, Albany, NY 12211. Editorial and
stagnant, you get run over as the world moves past you. We need to embrace advertising offices are at Suite 602, 20 Corporate
Woods Boulevard, Albany, NY 12211. Telephone (518)
change, but we also have to be the agents of that change. In that way, we will be
465-0044. Fax (518) 465-3219. E-mail info@nysdental.
the ones who control the outcome, adding to the possibility of our survival. We org. Website www.nysdental.org. Microform and article
copies are available through National Archive Publish-
need to be innovative. We must think outside the box to solve the problems we
ing Co., 300 N. Zeebe Rd., Ann Arbor, MI 48106-1346.
face. If not us, then who? I would not want someone who knows nothing about
dentistry deciding dentistrys future. How about you?
I didnt think so.
D.D.S.
Wisdom
Experience and conviction come into play when the dentist and patient disagree on the treatment plan.
ABSTRACT
Restorative dentists are often faced with the challenge interests in mind. To prejudge and propose treatment that falls short
of the benchmark for what we believe is appropriate, necessary and
of weighing best practice treatment plans against the
predictable because that little inner voice is forewarning patient re-
treatment requests of their patients. I believe we all fusal is a window to the fear and anxiety pervasive in the relationship
must ask ourselves prior to performing any dental between patient and dentist. How ironic that it is the dentist who
may become anxious anticipating that the recommended treatment
procedure, How do I know this restoration will be
will cause the patient to say no, or worse, goodbye.
successful, given the multitude of physiological, path- Who wants to lose a patient? Definitely not me. And if my guess
ological and anatomical limitations that can affect is correct, not you either! Walt Disney once said, When you believe
in a thing, believe in it all the way, implicitly and unquestionably.
the prognosis? There is no restorative dental proce-
Each of us has several unique beliefs regarding patient care. We each
dure that is free of risk. The purpose of this article is manage the doctor-patient interpersonal relationship differently.
to examine an interesting and somewhat controver- We also have preconceptions regarding dental procedures, restor-
ative materials, prognoses and the quality of laboratory prosthetics.
sial restorative case that illuminates perception and We use these principles and morals to regulate our behavior in the
judgment and the consequences of risk assessment. operatory. And we often apply them in our daily lives outside of the
office. William Whewell (1794-1866), English scientist, philosopher
As health care professionals, we are obligated to perform the best and theologian, envisioned prudence as the virtue by which we se-
we can every day and to improve upon what we learned yesterday. lect right means for given ends, while wisdom implies the selection
Every great accomplishment starts with the decision to try and to of right ends as well as right means. All of us possess knowledge and
trust that little voice in our head. Its difficult to mature into ones the skills to perform a multitude of procedures. Questioning which
greatest self, but its a tragedy to let fear stop us. So understand treatment options are wise and which minimize risk, while maximiz-
right now that fear is only as deep as our mind allows it to be. ing predictability, is whats important.
Theres a saying I learned shortly after graduating from dental As an experienced practitioner, educator and author, I share
school: You have to be willing to lose the patient before you can tru- with you now a simple restorative dental predicament that ex-
ly keep him or her. Its application to dentistry is rather straightfor- emplifies the challenges we face in our practices when a patient
ward. We need to recommend a treatment plan that is based upon refuses a treatment plan we have judged to be the most appropri-
sound scientific principles and that has the patients best oral health ate and predictable given the particular clinical circumstances.
REFERENCES
1. Daniela ED, Kalizia MO,Clarissa RF, et al. Surgical crown lengthening: a 12-month study-
radiographic results. J Applied Oral Sci 2007; Aug; 15(4): 280284.
2. Heydecke G, Peters MC, The restoration of endodontically treated, single-rooted teeth with
cast or direct post and cores: a systematic review. J Prosthet Dent 2002 Apr;87(4):380-386.
C
G. Kirk Gleason, D.D.S.
oncerns about the well-being of children brought close vide dental care to more preschool-aged children through edu-
to 40 professionals to Albany in June to participate in a two-day cation, treatment and prevention. So far, it has brought portable
workshop devoted to the Current State of Childrens Dental dental care to seven sites throughout Central and Western New
Health. The workshop was sponsored by the New York State York. Through education, it has successfully helped families
Dental Foundation. Moderator was Meg Atwood, R.D.H., M.P.S., change their behavior and has heightened their caries preven-
associate professor in the Department of Dental Hygiene at Or- tion knowledge.
ange County Community College. Bridget Walsh, M.P.H., from the Schuyler Center for Analysis
Among those gathered for the event in the Legislative Office and Advocacy (SCAA) discussed Keep NY Smiling, a project that
Building were dentists, registered dental hygienists, educators and has brought together SCAA, the Childrens Dental Health Project,
public health workers, with representatives from six of the best the Centers for Disease Control, the New York State Department
practices throughout New York State. Their objective was to learn of Health and HFWCNY to reduce ECC through the adoption of
about and develop strategies for treating, reducing and eradicat- evidence-based prevention strategies tailored to individual com-
ing early childhood caries (ECC). They were motivated by the munities. As such it takes into account local leadership, dental
awful knowledge that ECC can result in pain, increased risk of health statistics and existing programs. Once a strategy is chosen,
future caries, missed school days, visits to the ER and inpatient it is incorporated into the infrastructure of an existing program,
hospitalizations. thereby reducing costs and initial set-up time.
Kara Williams, M.P.H., from the Health Foundation for Melinda Clark, M.D., FAAP, from Albany Medical Center
Western and Central New York (HFWCNY) described an initia- and Albany Medical College explained how the separation of
tive named CHOMPERS! The program was developed to pro- medicine and dentistry is having a detrimental effect on oral
ABSTRACT
A review of the epidemiological, pathological and Rheumatoid arthritis (RA) is a chronic inflammatory disease of
immunological relationships between two chronic the joints characterized by loss of connective tissue and mineral-
ized structures, the so-called synovial membrane.1 It affects ap-
inflammatory diseases: rheumatoid arthritis (RA) proximately 1% of the total world population.2 It affects women
and periodontal disease (PD). RA is a chronic inflam- about three-times more often than men. Prevalence varies from
matory disease of the joints, characterized by loss 0.2% to 1.0% in various European, North American, Asian and
Australian populations.3 The prevalence of periodontal disease
of connective tissue and mineralized structures, the
has increased two-fold among patients with rheumatoid arthritis
so-called synovial membrane. Periodontitis is the compared to the general population.4 It affects all races, but is
inflammatory destruction of the periodontal attach- more common in Pima Indians5 and in the Chippewa Indians.6
Synovial and adjacent soft tissue inflammation may be initi-
ment and alveolar bone.
ated by a number of microbial factors, including bacterial DNA,
While the etiology of these two diseases may differ, heat shock proteins and lipopolysaccharides.7 MMPs, cathep-
the underlying pathogenic mechanisms are similar. sins and osteoclast activation contribute to bone resorption.8,9 A
number of cytokines, like TNF-a, IL-1 and macrophage colony-
And it is possible that individuals manifesting both PD
stimulating factor (MCSF), are also involved.10 Epigenetic changes
and RA may suffer from a unifying underlying system- through the regulation pro-inflammatory response through
ic deregulation of the inflammatory response. There is NF k B regulation affecting TNF alpha may be crucially involved
in the pathology of RA and other chronic inflammatory diseases.
an overproduction of a variety of cytokines and MMPs
Chronic periodontitis and RA appear to share many common
that appears to be common in both diseases. Oral pathological features. Oxygen metabolism has an important role
health parameters should be more closely monitored in the pathogenesis of both CP and RA. However, the presence of
RA seems not to affect local and systemic Oxidative Stress Index
in patients with RA, an autoimmune disease. Data sug-
values in patients with chronic periodontitis.11
gest that periodontal therapies combined with routine RA can affect any joint, but it is usually found in metacarpo-
RA treatments further improve RA status. Interven- phalangeal, proximal interphalangeal and metatarsophalangeal
joints, as well as in the wrists and knee. The clinical presentation
tions to prevent, minimize or treat periodontitis in ar-
of RA varies, but insidious onset of pain with symmetric swelling
thritis patients will definitely promise a better quality of small joints is the most frequent finding. RA onset is acute or
of life for these patients. subacute in about 25% of patients, but its patterns of presen-
First Author Study Design Clinical Data Lab Data Findings Conclusion
& Reference and Characteristics
Ribeiro et 42 patients PPD,CAL ESR GROUP 2: More reduction on PPD Periodontal treatment with SRP
al.,200551 Group 1 (G1) -16 RF 4mm than GROUP 1 might have an effect on the ESR
Group 2 (G2)-26 Drug therapy reduction.
G1:OHI+tooth cleaning ESR was significantly reduced in G2
G2:SRP after SRP
Ortiz et RCT PD,CAL,BOP,GI,PI,RA ESR In patients receiving periodontal treat- Control of periodontal infection
al.,200952 40 pts with mod / disease activity ment, there is sig decrease in mean by SRP and oral hygiene in sub-
severe periodontitis scores(DAS-28) DAS28,ESR and serum TNF alpha jects with moderate periodontitis
20 test: SRP might contribute to reduction in
20 control: No therapy No sig decrease in patients who did signs and symptoms of RA and
20 pts: Anti-rheumatic not receive treatment reduction in serum levels of TNF
drugs alpha.
20 pts: Anti TNF alpha drug therapy: sig
Anti-rheumatic drugs improvement in CAL,BOP,PD,GI
+anti TNF alpha drug
Pischon et Association between PI, GI ,PD, CAL Subjects with RA had a sig 8.05 fold Subjects with RA have signifi-
al.,200853 RA and periodontitis increased odds of periodontitis. cantly increased attachment loss
was examined in compared to controls.
57 pts with RA and PI: Accounted for 12.4%, GI:11.1%,
52 healthy controls PI and GI combination:13.4% of
matched by age and the association between RA and
gender periodontitis.
Ziebolz et 60 RA pts. Pool samples 24pts-Gingivitis No association was found
al.,20111 Periodontal classifica- for PCR analysis 18 pts-moderate periodontitis between RF on periodontal
tion was assessed with for presence of 23pts -severe periodontitis classification and microbiologic
periodontal screening 11 periodontal parameters.
index PSR/PSI pathogens No sig influence of RF on periodon-
1: healthy tal classification and microbiological
2: gingivitis parameters.
3: moderate
periodontitis Smoking showed a sig influence on
4: severe periodontitis this classification and in the case of
E. corrodens.
Leksell et Case-control study. Plaque, calculus, Serum, RF, CRP, 68% JIA and 12% controls had pain 1.Children with JIA have more
al.,201211 Subjects between 10 PPD, CAL, and ESR, salivary when opening the mouth. 12% JIA oral ulcerations, discomfort,
and 19 years 41 juve- mucosal lesions flow rate. had intraoral ulcers. 32% JIA but plaque, BOP, and gingival
nile idiopathic arthritis dental radiographs. none in control group had increased hyperplasia.
(JIA) on DMARDS.41 Child health assess- PPD/IA+ subjects on anti-TNF-a had
control subjects. ment questionnaire lower BOP scores. Medications; 2. Children with JIA on
Stanford HAQ dis- Anti-TNF-a, DMARD, NSAIDS, and anti-TNF-a had less gingivitis.
ability index. methotrexate.
TABLE 3
Association Studies between Rheumatoid Arthritis and Periodontitis (Animal Studies)
Cantley et al., To develop an animal Alveolar bone and joint Mice with pre-existing periodontitis developed more Pre-existing periodon-
201154 model to assess the changes were assessed. severe arthritis. titis exacerbated
relationship between pre- Histological and Mice with periodontitis only also showed bone loss experimental arthritis in
existing periodontitis and immunohistochemistry. within the radiocarpal joint. mouse model.
experimental arthritis (EA) Serum levels of C-reactive Evidence of alveolar bone loss in mice with EA alone.
in mice. protein.
Authors do not have any conflict of interest in reviewing the topic. Queries
about this article can be sent to Dr. Almas at [email protected].
REFERENCES
1. Ziebolz D, Pabel SO, Lange K. Clinical periodontal and microbiologic parameters in patients
with rheumatoid arthritis. J Periodontal 2011;82:1424-32.
2. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmune Rev
2005; 4:130-6.
3. Silman AJ, Hochberg MC. New York: Oxford University Press; 2001. Epidemiology of the
rheumatic diseases.
4. Berthelot JM, Le Goff B. Rheumatoid arthritis and periodontal disease. Joint Bone Spine 77
(2010);77:537-41.
5. Del Puente A, Knowler WC, Pettitt DJ, Bennett PH. High incidence and prevalence of rheu-
matoid arthritis in Pima Indians. Am J Epidemiol 1989;129:1170-8.
6. Harvey J, Lotze M, Stevens MB. Rheumatoid arthritis in a Chippewa Band. I. Pilot screening
study of disease prevalence. Arthritis Rheum 1981;24:717-21.
7. Albani S, Carson DA, Roudier J. Genetic and environmental factors in the immune patho-
genesis of rheumatoid arthritis. Rheum Dis Clin North Am 1992;18:72940.
8. Haynes DR, Crotti TN, Loric M, Atkins GJ, Findlay DM. Osteoprotegerin and receptor acti-
vator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the
human rheumatoid arthritic joint. Rheumatology 2001;40:62330.
9. Woolley DE, Tetlow LC. Observations on the microenvironmental nature of cartilage deg-
radation in rheumatoid arthritis. Ann Rheum Dis 1997;56:15161.
10. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the
cartilage/pannus junctions in patients with rheumatoid arthritis: implications for the role
of cytokines in cartilage destruction and repair. Br J Rheumatol 1992;31:65361.
11. Leksell E, Ernberg M, Magnusson B, Hedenberg-Magnusson B. Intraoral condition in
children with juvenile idiopathic arthritis compared to controls. Int J Paediatr Dent
2008;18:423-33.
12. Grassi W, De Angelis R, Lamanna G, Cervini C. The clinical features of rheumatoid arthritis
Eur J Radiol 1998; S18-24.
13. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001;358:903-11. Review.
14. Papapanou PN. Periodontal diseases: epidemiology. Ann Periodontol 1996;1:136.
15. Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine regulation for periodontal
treatment: fibroblast biology. J Periodontol. 2003;74:10310.
16. Albandar JM. Underestimation of periodontitis in NHANES surveys. J Periodontol
2011; 82:337-41.
17. Rutger Persson G. Rheumatoid arthritis and periodontitisinflammatory and infectious
connections. Review of the literature. Oral Microbiol 2012;4. Epub Feb 13.
18. Saini R. Periodontitis: a true infection. J Glob Infect Dis 2009;1:149151.
19. Listgarten MA. Bacteria and periodontitis. J Can Dent Assoc 1996;62:12-13.
ABSTRACT
The authors present a case study of a 13-year-old fe- frequently shaped like butterfly wings.2,3 With the advent of new
male with a past medical history of tuberous sclerosis techniques for genetic studies, it is currently understood that TSC
is an autosomal dominant disease with high penetrance, and that
complex (TSC), an autosomal dominant disorder. It
males and females have a 50% chance of passing the affected gene
usually presents with a triad of epilepsy, mental de- to their offspring.4 It is caused by inactivating mutations of TS1
ficiency and facial angiofibromas that are often dis- and TS2 tumor suppressor genes located on chromosomes 9q34
and 16p13.3, respectively, leading to cellular hyperproliferation
tributed around the nose, cheek and chin, and are
and harmatoma formation in different organs of the body, most
frequently shaped like butterfly wings. In addition, commonly, the kidneys, heart, eyes, gingiva, skin and brain.2,5,6
oral manifestations include gingival enlargement and No single organ is affected in every patient diagnosed with TSC;
and there is no proof that any single clinical or radiographic sign
developmental enamel pitting on the facial aspect of
present in one organ is absolutely specific for TSC.6
the anterior permanent dentition in 50% to 100% of Diagnosis is usually made by clinical, pathologic and/or radio-
patients. The patients chief complaint was gingival graphic findings. Because of the variation in symptoms of TSC dis-
order, the diagnosis of TSC has been divided into major and minor
enlargement and gingival bleeding. The histology of
criteria. A patient is said to definitely have TSC if he or she presents
the excised gingival tissue revealed epithelial and fi- with two major features or one major feature and two or more minor
brous hyperplasia, consistent with TSC. features.7-10 Probable TSC diagnosis is reached if a patient presents
with one major and one minor feature, while a diagnosis of pos-
Tuberous sclerosis complex (TSC), also known as Bournevilles sible TSC is made if the patient presents with one major feature or
disease or epiloia, is an autosomal dominant disorder with a two or more minor features (Table 1).7-10 However, patients should
neurological manifestation. It was first documented in 1862 by be considered for the syndrome if they present with a history of sei-
Von Recklinghausen in a brief report and then more thoroughly zures and hypomelanotic lesions, as 90% of patients present with
described in 1880 by Desire-Magloire Bourneville, who observed seizures and up to 98% present with skin lesions.7,10
that the disease was only suspected in patients that presented Oral manifestations of TSC include developmental enamel
with mental retardation and fits.1,2 pitting on the facial aspect of the anterior permanent dentition in
In 1908, Vogt described TSC as a disorder that presents with a 50% to 100% of patients.2,11,12 The pathogenesis of pitted enamel
triad of epilepsy, mental deficiency and facial angiofibromas that hypoplasia in TSC is not understood. Previous studies suggest that
are often distributed around the nose, cheek and chin, and are the pits extend to the dentoenamel junction. The pits appear to
Case Report
A 13-year-old female presented to Brookdale University Hospital
dental clinic for comprehensive dental care and gingival bleed-
Figure 1. Reveals facial angiofibromas consisting of blood vessels and fibrous tissue, and
Shagreens patch on the back, Periungual fibromas (Koenens tumor) on thumb. ing from the areas of overgrowth. She had been an inconsistent
patient since 2004. A medical clearance from her primary care
physician, dated June 2008, described her past medical history as
tuberous sclerosis with skin lesions/seizure disorder and learn-
ing issues and two small rhabdomyomas in the left ventricle with
good heart function, and shagreens patch on her back. She is
on Keppra (levetiracetam) 250 mg two times a day and has no
known drug allergies. Extraoral exam shows facial angiofibromas;
no swelling, no lymphadenopathy and no tempro-mandibular
disorder were observed (Figure 1).
The intraoral exam showed missing permanent first molars
(#3, #14, #19, #30), which were extracted in 2006. Notes from
her clinic chart stated the first molars were extracted due to
dysmorphic and abnormal development; hypoplastic maxillary
central incisors (#8 and #9), gingival enlargement about 2 cm by
1 cm on facial gingival papilla between #23 and #24; gingival en-
largement also observed between facial papilla of #7,#8, #9 and
Figure 2. Gingival overgrowth between #23 and #24 showing low smile line. lingual of #6 and #7; ankylosed and over-retained primary tooth
#K, edge-to-edge incisal occlusion, and rotated #28 (Figures 2-4).
Discussion
TSC is an autosomal dominant neuro-cutaneous disorder char-
acterized by the development of multiple hamartomas distributed
throughout the body, skin, brain, heart, kidneys, liver and lungs.15
Two-thirds of the patients report sporadic mutations. It is usually
associated with the classic of mental retardation (in 70% of cas-
es), seizures (in 90% of cases) and angiofibromas (95% of cases).
However, this classic triad is only present in 29% of patients with
the disorder; 6% of these patients lack all three.2,16 Oral mani-
festations such as enamel pitting and fibromatous growth of the
gingiva are also seen in patients with TSC, and are considered
minor features of the disorder.7,16,17
Figure 5. Anatomical crown exposure and gingivectomy.
In the case presented here, the patient appeared with the
classic triad of history of seizure disorder, learning issues and
angiofibromas, with a butterfly-like pattern on the face;18,19 In
addition, a consultation with her primary care physician revealed
she had cardio-rhabdomyomas, facial angiofibromas and periun-
gual fibromas (Koenens tumor); these are all major features of
the disorder. Thus, her diagnosis of TSC is definite.
Her chief complaint was gingival overgrowth that bleeds
when she brushes, which affects her home care and negatively
affects her quality of life. She was not concerned about her esthet-
ics but, rather, difficulty brushing and flossing. We decided on
minimal gingival reduction and restorative treatment until she
was older. Her treatment plan included oral hygiene instructions, Figure 6. Two-month postsurgery.
The ADA VISA Signature card allows for travel on more than 150
airlines with no black-out dates. You need only 25,000 points to
earn a $450 ticket. Apply today, get approved and earn 10,000
bonus points after you spend $3,000 in the first 90 days.
For more information about this and other Endorsed Programs call: 800-255-2100
REFERENCES
1. Flanagan N, OConnor WJ, McCartan B, Miller S, McMenamin J, Watson R. Develop-
mental enamel defects in tuberous sclerosis: a clinical genetic marker? Jr Med Gene
1997;34(8):637-639.
2. Stalker HJ (editor), Zori R T (director). Tuberous Sclerosis. R. C. Phillips Units Newsletter
July 2005; XVII (1).
3. Osborne JP. Diagnosis of tuberous sclerosis. Arch Dis Child 1988;Dec 63(12):1423-5.
4. Napolioni V, Curatolo P. Genetics and molecular biology of tuberous sclerosis complex.
Curr Genomics 2008;Nov 9(7):475-87.
5. Vargas-Gonzalez R, San Martin-Brieke W, Gil-Ordua C, Lara-Hernandez F. Desmoplastic
fibroma-like tumor of maxillofacial region associated with tuberous sclerosis. Pathol Oncol
Res 2004;10(4):237-9. Epub 2004 Dec 27.
6. Rodrigues DA, Gomes CM, Costa IM. Tuberous sclerosis complex. An Bras Dermatol 2012
Mar-Apr;87(2):184-96.
7. Schwartz RA, Fernndez G, Kotulska K, Jwiak S. Tuberous sclerosis complex: advances in
diagnosis, genetics, and management. J Am Acad Dermatol 2007 Aug;57(2):189-202.
8. Korol UB, Schoor R, Nanda V, Almas K, Phelan JA. Gingival enlargement as a manifesta-
tion of tuberous sclerosis: case report and periodontal management. J Periodontol 2008
Apr;79(4):759-63.
9. http://www.tsalliance.org/pages.aspx?content=54. Diagnostic Criteria Accessed Dec. 26, 2013.
10. Teng JM, Cowen EW, Wataya-Kaneda M, Gosnell ES, Witman PM, Hebert AA, Mlynarczyk G,
Soltani K, Darling TN. Dermatologic and dental aspects of the 2012 International Tuberous
Sclerosis Complex Consensus Statements. JAMA Dermatol 2014 Oct;150(10):1095-101.
11. Lpez-Lpez J, Rodrguez-de-Rivera-Campillo E, Marques-Soares MS, Finestres-Zubeldia F,
Chimenos-Kstner E, Rosell-Llabrs X. Tuberous sclerosis and its oral manifestations. A
clinical case. Med Oral 2004 May-Jul;9(3):216-23.
12. Devlin LA, Shepherd CH, Crawford H, Morrison PJ. Tuberous sclerosis complex: clinical
features, diagnosis, and prevalence within Northern Ireland. Dev Med Child Neurol 2006
Jun;48(6):495-9.
13. Araujo Lde J, Lima LS, Alvarenga TM, Martelli-Jnior H, Coletta RD, de Aquino SN, Bonan
PR. Oral and neurocutaneous phenotypes of familial tuberous sclerosis. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod 2011 Jan;111(1):87-94. Epub 2010 Nov 4.
14. Martelli H, Lima LS, Bonan PR, Coletta RD. Oral manifestations leading to the diagnosis of
familial tuberous sclerosis. Indian J Dent Res 2010 Jan-Mar;21(1):138-40.
15. Nath J, Dubey A, Pavan R. Analysis of twenty pediatric cases of tuberous sclerosis complex:
are we doing enough? Indian J Dermatol Venereol Leprol 2015 Jan-Feb;81(1):23-8.
16. Gutte R, Khopkar U. Unilateral multiple facial angiofibromas: a case report with brief review
of literature. Indian J Dermatol 2013 Mar;58(2):159.
Ortho-Perio Interrelationship
Treatment Challenges
Nidhi Rathore, B.D.S., M.D.S.; Asavari Desai, B.D.S., M.D.S.; Mridula Trehan, B.D.S., M.D.S.;
Vikas Jharwal, B.D.S., M.D.S.; Lakshmi Puzhankara, B.D.S., M.D.S.; Anand Marya, B.D.S.
ABSTRACT
It is an undisputed fact that sound periodontal health treatment can be carried out safely and satisfactorily, even in the
is a prerequisite for successful orthodontic therapy. presence of previous alveolar bone loss.
Thus, the primary aim before commencing orthodontic treat-
Various complex dental problems necessitate a mul- ment is to stabilize the periodontal condition.3 The aim of this article
tidisciplinary approach; there cannot be a better is to review the benefits of integrating orthodontics and periodontics
example than an ortho-perio interaction. Certain in the management of periodontally compromised patients.
Nidhi Rathore, B.D.S., M.D.S., is senior lecturer, Department of Orthodontics and Dentofacial
Orthopedics, Eklavya Dental College and Hospital, Rajasthan University of Health Sciences, Kotputli,
Rajasthan, India.
Asavari Desai, B.D.S., M.D.S., is senior lecturer, Department of Orthodontics and Dentofacial
Orthopedics, Manipal College of Dental Sciences, Manipal University, Mangalore, Karnataka, India.
Mridula Trehan, B.D.S., M.D.S., is professor and head of the Department of Orthodontics and
Dentofacial Orthopedics, Mahatma Gandhi Dental College and Hospital, Mahatma Gandhi University of
Medical Sciences and Technology, Jaipur, Rajasthan, India.
Vikas Jharwal, B.D.S., M.D.S., is senior lecturer, Department of Orthodontics and Dentofacial
Orthopedics, Mahatma Gandhi Dental College and Hospital, Mahatma Gandhi University of Medical
Sciences and Technology, Jaipur, Rajasthan, India.
ABSTRACT
Methadone is a Schedule II drug best known for its Pharmacology
use in the treatment of opioid dependence. Dental Methadone occurs in R-enantiomeric and S-enantiomeric forms,
with the majority of activity due to the activity of R-methadone.
providers should be aware of the oral and systemic It is a lipid soluble drug; estimates of the half-life are between 15
effects of methadone. In patients undergoing metha- to 55 hours.6,7 Methadone has high oral bioavailability, so it gives
done maintenance therapy, there is a higher incidence reliable effects when administered orally; both tolerance and physi-
ological dependence develop more slowly than with morphine.8
of rampant caries, xerostomia, bruxism and poor oral Methadone exerts its activity through binding to and activat-
hygiene. A review of the pharmacology, systemic ef- ing opioid receptors centrally and in the periphery. This activity
fects, drug interactions and oral manifestations is produces the effects common to all opioid agonists: analgesia,
euphoria, constipation, sedation, respiratory depression, nausea
presented, as well as possible modifications to treat- and miosis. Additionally, methadone antagonizes N-methyl-D-
ment and specific considerations in dental therapies. aspartate receptors, which may increase its effectiveness in the
treatment of neuropathic pain compared with other opioids.9
Methadone was approved by the Food and Drug Administration Methadone binds directly to proteins and to plasma proteins,
in 1972 as a treatment for opioid addiction. Research began in chiefly albumin, globulins, and alpha 1-acid glycoprotein. Steady
1964 at Rockefeller Hospital in the then-Rockefeller Institute for state is not attained until methadone is fully distributed and
Medical Research.1 bound in tissues. Therefore, blood levels continue to rise slow-
Methadone prevents cravings while blocking the euphoric ly for four to six weeks. Although patients sometimes complain
effects of heroin to establish abstinence.2,3 Originally the hope about drug formulation changes (tablets versus liquid; differing
was that refraining from heroin would decrease criminal activity flavors), there are no correlated changes in pharmacokinetics or
as well but, according to a 2009 Cochrane review, methadone dynamics.7
maintenance treatments decreased the likelihood that heroin- The route of metabolism of methadone is hepatic and in-
dependent patients would use heroin, but it did not change crime volves the cytochrome p-450-related enzymes. The methadone is
or mortality rates.4 broken down into two biologically inactive metabolites, a pyrro-
There are currently over 1,400 methadone maintenance line and a pyrrolidine, which are further metabolized.1,10,11 These
therapy (MMT) centers in the United States.5 There are well- are eliminated by the kidney and excreted through the bile. In
documented drug interactions with methadone that will be dis- total, nine metabolites have been identified, including two minor
cussed, along with the effect of alcohol on methadone levels. active metabolites, methadol and normethadol.12
Systemic Manifestations
In a well-controlled methadone maintenance therapy patient,
the two most common side effects are constipation and sweat- Methadone levels are also affected by the regular intake of more
ing.1,14 Other side effects include sedation, nausea, vertigo, em- than four alcoholic beverages a day. Studies performed on 129
esis and pruritis.1,15 long-term MMT men and women indicated that although one
Metabolism of methadone can be affected by interactions of quarter of the cohort reported four or more drinks a day, there
other medications, such as phenytoin, carbamazepine, rifampi- were no significant changes in liver enzymes after three years of
cin, fluconazole and some protease inhibitors. These drugs cause MMT.1,20 These findings indicate that MMT does not potentiate
an increase in the metabolism of methadone.16 If taken concur- alcohol-induced hepatotoxicity.1,20
rently, erythromycin and ketoconazole may enhance the risk of
a methadone overdose in susceptible individuals due to their Dental Manifestations
potential to inhibit the metabolism of methadone. Fluoxetine Residual effects from heroin addiction are often prevalent in
(Prozac) can also increase the plasma concentration of metha- MMT patients. Rampant caries, poor oral hygiene, xerostomia
done, as can other selective serotonin reuptake inhibitors.16-18 and periodontal disease are frequently lingering effects of the
Higher doses of methadone (200 mg to 400 mg/day) have time spent abusing opioids.
been implicated in prolongation of the QT interval on electro- The MMT patient may present as part of a referral program,
cardiogram and, possibly, with Torsades de pointes.1 Torsades is a or be genuinely interested in restoring his or her oral health. Her-
form of ventricular tachycardia manifested by episodes of alter- oin addiction produces xerostomia with hypoglycemia. Individu-
nating polarity with the amplitude of the QRS complex twisting als combat this with frequent ingestion of sugar (chocolate, sugar
around an isoelectric baseline. The rhythm usually starts with a cubes), resulting in rampant caries.21 The altered taste preference
pre-ventricular contraction and is preceded by a widening of the for sweet foods seen in heroin addiction continues into many pa-
QT interval.19 tients on MMT. This high cariogenic diet is compounded in these
CareCredit Helps
Your Patients Say, Yes!
Contact CareCredit today to receive your free referral kit, featuring an educational paper from
Bernie Stoltz, CEO, Fortune Management. Call them at 866-304-9064 or visit carecredit.com/
practices/dental/.
For more information about this and other Endorsed Programs call: 800-255-2100
Queries about this article can be sent to Dr. Maloney at [email protected]. George Raymond, D.D.S., is clinical instructor in the Department of Cariology and Comprehensive
Care, New York University, New York, NY.
REFERENCES
1. Kreek MJ, Borg L, Ducat E., Ray B. Pharmacotherapy in the treatment of addiction: metha- William James Maloney, D.D.S., is clinical associate professor in the Department of Cariology
done. J Addict Dis 2010 Apr;29(2):200-16. and Comprehensive Care, New York University College of Dentistry, New York, NY.
2. Brondani M, Park P. Methadone and oral health: a brief review. J Dental Hygiene
2011;85:92-98.
3. Farnsworth N. Oral health project for people on methadone programs & with substance
abuse issues in the outer metropolitan region. Department of Health (internet). 2004.
Available from: www.health.vic.gov.au/healthpromotion/downloads/fr_knox.pdf
4. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid
replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2003 CD002209.
5. National Institute on Drug Abuse. Study Supports Methadone Maintenance in Thera-
peutic Communities. Retrieved from http://www.drugabuse.gov/news-events/nida-
notes/2010/12/study-supports-methadone-maintenance-in-therapeutic-communities.
Accessed March 29, 2013.
6. Brown R, Kraus C, Fleming M, Reddy S. Methadone: applied pharmacology and use as
adjunctive treatment in chronic pain. Postgrad Med J 2004;80:650-659.
7. Eap CB, Buclin T, Baumann P. Inter-individual variability of the clinical pharmacokinetics
of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet
2002;41:1153-1193.
8. Katzung B, editor. Basic & Clinical Pharmacology. 7th ed. Stamford: Appleton & Lange.
1998; pp. 504-505.
9. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain 2002;18:S313.
10. Ferrari A, Coccia CP, Bertolini A, Sternieri E. Methadone metabolism, pharmacokinetics
and interactions. Pharmacol Res 2004;50:551-559.
11. Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Phar-
macother 2005;19:13-24.
12. Felder C, Uehlinger C, Baumann P, Powell K, Eap CB. Oral and intravenous methadone use:
some clinical and pharmacokinetic aspects. Drug & Alcohol Dependence 1999;55:137-43.
13. CDC Department of Health and Human Services. Methadone management therapy. Febru-
ary 2002. Available at www.cdc.gov/idu.
14. Kreek MJ. Medical safety and side effects of methadone in tolerant individuals. JAMA
1973;223:665-668.
15. Gutstein HB, Akil H. Opioid Analgesics. In: Brunton L, Lazo JS, Parker KL., editors. Good-
man and Gilmans the Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw-
Hill. 2005; pp.547-590.
16. Corkery J, Fabrizio S, Ghodse A, Oyefeso A. The effects of methadone and its role in fatali-
ties. Hum Psychopharmacol Clin Exp 2004;19:565-576.
17. Furet Y, Gibier L, Clarte C. Aspects pharmacologiques des programmes de substitution pour
les toxicomanes aux opiaces [Pharmacologic aspects of substitution programs for opiate
addiction]. Revue Med Tours 1999;33:153-158.
18. Bertschy G, Baumann P, Eap CB, Baettig D. Probable metabolic interaction between metha-
done and fluvoxamine in addict patients. Ther Drug Monitor 1994;16:42-45.
19. Ferri F, editor. Practical Guide to the Care of the Medical Patient. 5th ed. St. Louis:Mosby.
2001;pp 151-154.
20. Kreek MJ. Plasma and urine levels of methadone. NY State J Med 1973;73:2773-2777.
21. Sheedy J. Methadone and caries. Case reports. Australian Dental J 1996;4(6):367-9.
22. Titsas A, Ferguson MM. Impact of opioid use on dentistry. Australian Dental J
2002;47(2):94-98.
23. Scheutz F. Anxiety and dental fear in a group of parenteral drug addicts. Scand J Dent Res
1986;94:241-247.
24. Patton L, editor. The ADA Practical Guide to Patients with Medical Conditions. 1st ed. Iowa:
Wiley-Blackwell. 2012;pp 344-346.
Differential Diagnosis of a
Periapical Radiolucent Lesion
A Case Report and Review of the Literature
Matthew Malek, D.D.S.; Lina M. Cortes, D.D.S.; Asgeir Sigurdsson, D.D.S., M.S.; Paul A. Rosenberg, D.D.S.
ABSTRACT
This article demonstrates a methodological approach Establishing an accurate diagnosis for a periapical lesion may be
to diagnosing a periapical radiolucency that could not challenging, especially when the nature of the lesion cannot be
determined through basic diagnostic tests. The most important
be diagnosed using only basic clinical and radiograph- question to be addressed is the origin of the lesion, since radio-
ic findings. The patient was a 59-year-old Hispanic graphic bone changes that mimic lesions of endodontic origin
female with a small tender mass on the lower gingi- may occur as a consequence of neoplastic and developmental al-
terations.1
va associated with tooth #25. Radiographic appear- The initial diagnostic step is to determine whether the le-
ance demonstrated a well-defined radiolucent lesion sion is of endodontic origin. This is most often accomplished
at the apices of the mandibular incisors. The patient through use of high-quality radiographs and a thorough clinical
examination, including sensibility tests. Interpretation of periapi-
had no significant medical history. Cone-beam com- cal radiography may lead to subjective conclusions;2 and there is
puted tomography (CBCT) showed bony expansion insufficient evidence to determine the diagnostic accuracy of pulp
of the buccal plate. Differential diagnosis included sensibility tests.3 Therefore, relying solely upon periapical radio-
graphs and inconclusive clinical tests may lead to misdiagnosis
non-endodontic unilocular radiolucent lesions in and unnecessary treatment for a healthy tooth with a periapical
the anterior mandibular region. Biopsy findings were radiolucency.4,5
consistent with periapical cemento-osseous dysplasia When diagnosing an apical radiolucent lesion seemingly
associated with vital teeth, the clinician should follow an or-
(PCOD). In conclusion, clinical appearance of PCOD ganized thought process to reach a definite diagnosis.6 Some
varies from non-expansile and asymptomatic to being lesions may be accurately diagnosed through radiographs and
expansile and sometimes symptomatic. In the latter clinical findings.7 But in cases where the diagnosis is not clear,
the clinician would benefit from other diagnostic methods to
cases, it may be necessary to use additional diagnostic further evaluate the lesion. Studies have shown that a high-
tools to confirm the diagnosis. resolution, three-dimensional technique, such as cone-beam
Case Report
A 59-year-old Hispanic female was presented for the purpose of
root canal treatment on the mandibular right central incisor. Her
chief complaint was pain upon palpation around the gingival tis-
sue of the mandibular central incisors. Her medical history was
noncontributory (Figure 1).
Figure 1. Preoperative intraoral image. Arrow is pointing to area of gingival mucosa where
Radiographic Appearance
hard swelling was palpable.
The radiograph showed a relatively well-defined radiolucency
with slightly irregular borders at the apices of the mandibular left
and right central incisors (Figure 2). No caries, restorations or
fractures were present on the mandibular anterior teeth. Intraoral
and radiographic examination revealed normal probing depths
and mild-to-moderate generalized chronic periodontitis. A small
tender mass was noted on the gingival mucosa of the mandibular
right central incisor.
All four mandibular incisors responded normally to Endo Ice
(Coltene/Whaledent Inc., Newark, NJ) and to the electrical pulp tester
(Sybron Endo, Orange, CA). No percussion sensitivity was detected
on the four anterior incisors, but the gingival mucosa around the
apex of the mandibular right central and lateral incisors was sen-
sitive to palpation. Figure 2. Preoperative periapical ra- Figure 3. Sagittal section of mandibular right
diograph of mandibular anterior teeth, central incisor, showing extent of expansion.
Cone Beam Computed Tomography (CBCT) revealing periapical radiolucency.
In order to evaluate the nature and extent of the lesion and its
expansion, we utilized a CBCT. On panoramic reconstruction, we
noted a large lytic lesion in relation to the mandibular anterior
teeth. In the cross-section view, the lesion appeared to have ex-
panded the mandibular cortices and measured approximately 10
mm 7 mm. The lesion extended from the apex of the mandibu-
lar left central incisor to the apex of the mandibular right lateral
incisor (Figures 3, 4).
Considering tooth vitality, the differential diagnosis includ-
ed non-endodontic unilocular radiolucent lesions that can be
found in the anterior mandibular region. These lesions include
Figure 4. Inferior view of axial section showing labial extension of lesion and its relation to
the following: periapical cemento-ossesous dysplasia (PCOD);9 roots of mandibular incisors. Arrows are pointing to bony expansions on buccal and lingual plates.
central giant cell granuloma (CGCG);6 ameloblastoma;11 poor-
Histopathological Analysis
Histological sections demonstrated cellular fibrovascular tissue
with plump fibroblasts and scattered foci of new bone, osteoid
and cementum-like material with associated osteoblasts and os-
teoclasts. There were also a few infiltrating chronic inflammatory
cells. The histopathological diagnosis was benign fibro-osseous le-
sion and in view of the radiographic findings was consistent with
periapical cemento-osseous dysplasia (Figure 5).
We informed the patient of the diagnosis and explained the
prognosis to her, which based upon the self-limiting, non-progres-
sive nature of the lesion, was considered to be good. At the one-year
follow-up, radio-opaque areas were visible in the lesion; all four
anterior mandibular teeth responded normally to pulp tests; and
while the patient still experienced some mild sensation upon pal-
Figure 5. Histology slide with x20 magnification, demonstrates cellular fibrovascular tissue
pation, the tender mass on the labial mucosa was gone (Figure 6).
with plump fibroblasts and scattered foci of new bone, osteoid and cementum-like material
with associated osteoblasts and osteoclasts.
Discussion and Review of Literature
PCOD was originally classified as a type of cementoma. In 1992,
it was removed from the World Health Organization (WHO)
classication of odontogenic tumors and placed among the bro-
osseous bone lesions.18 This lesion, along with focal cemento-osse-
ous dysplasia and florid cemento-osseous dysplasia, form cemento-
osseous dysplasia (osseous dysplasia), one of the most common
groups of fibro-osseous lesions encountered in clinical practice.19
PCOD has three radiographic features that indicate stages
from early formation to maturation: 1. osteolytic; 2. cementoblas-
tic; and 3. mature. In the early stage of osteolytic, lesions are well-
dened radiolucencies at the apex of one or more teeth.18 The his-
tologic appearance demonstrates fibrous connective tissue mixed
with woven bone, lamellar bone and cementoid particles. This ap-
pearance changes with the stage of maturation, such that as the
lesion matures, the ratio of fibrous connective tissue to mineralized
material decreases.19 The calcied structures in the osteolytic stage
Figure 6. Postoperative, are of insufcient size to be observed radiographically.18
one-year follow-up radiograph PCOD is a benign, slowly growing tumor.20 In most cases, no
shows scattered radio-opaque
further treatment is necessary after its diagnosis.18 In some cases,
calcific areas in lesion.
when a cemento-osseous lesion becomes significantly sclerotic,
ABSTRACT
Plasma cell gingivitis, an infrequently observed oral cally characterized by diffuse gingival enlargement, erythema and
condition, has been clinically characterized by diffuse sometimes desquamation.1-3 These lesions are usually asymptom-
atic, but invariably the patient will complain of a burning sensa-
gingival enlargement, erythema and sometimes des-
tion in the gingiva4 and bleeding from the mouth.5-8
quamation. These lesions are usually asymptomatic, PCG is known by a variety of other names. They include
but invariably the patient will complain of a burn- atypical gingivostomatitis,9 idiopathic gingivostomatitis,4 allergic
gingivostomatitis10 and plasmacytosis of the gingiva.11 A localized
ing sensation in the gingiva and bleeding from the
lesion called plasma cell granuloma has also been reported by
mouth. The diagnosis requires hematological screen- Phadnaik et al.12
ing in addition to clinical and histopathological ex- Although the etiopathogenesis of PCG is still not clearly
understood, it is considered a hypersensitivity reaction to some
aminations. This case report outlines one such case of
antigens, such as the components of chewing gums and dentifric-
plasma cell gingivitis in a 15-year-old female caused es.3,5,13-14 Flavoring agents added to chewing gums and dentifrices
by use of an herbal, homemade toothpowder. The case can produce an inflammatory reaction in both free and attached
gingiva. The most prominent microscopic picture of plasma cell
presented here highlights the adverse effects and irra-
gingivitis is diffuse and massive infiltration of plasma cells into
tional use of herbal agents in dentifrices. At the same the sub-epithelial connective tissue, resulting in disruption or
time, it emphasizes the need for comprehensive his- damage to the basement membrane. The capillaries in the con-
tory taking, careful clinical examination and appro- nective tissue may also become dilated.6-8
It is important to be able to differentiate PCG from other
priate diagnostic tests in order to arrive at a definitive
mucous membrane lesions affecting the gingival tissues. Often,
diagnosis and treatment plan for gingival conditions microscopic examination is necessary to make this distinction.
that are refractory to conventional therapy and to ex- The diagnosis requires hematological screening in addition to
clinical and histopathological examination. Pathological changes
clude certain malignancies and oral manifestations of
in this condition are clinically similar to those of pemphigus,
systemic diseases. pemphigoid, desquamative gingivitis, lichenoid or allergic reac-
tions, anti-seizure (such as Dilantin) or calcium channel blocker
Plasma cell gingivitis (PCG) is an uncommon inflammatory hyperplasia and a leukemic infiltrate, which must be differenti-
condition of uncertain etiopathogenesis. PCG has been clini- ated through hematologic and serologic testing.3,11-14 It has been
Figure 3. Histopathological picture showing dense infiltration of lymphocytes with scattered Figure 4. Histopathological picture showing thickened epithelium with widened rete-pegs.
plasma cells and neutrophilic abscesses.
observed that histopathological changes of PCG mimic those of tion. The patient first noticed a mild reddish discoloration around
multiple myeloma or solitary plasmacytoma.3 five months ago, which progressively increased in size without
This case report concerns plasma cell gingivitis in a 15-year- any apparent discomfort.
old female caused by the use of herbal, homemade toothpowder. Clinical examination revealed severe inflammation of the
gingival tissues extending from the free gingival margin to the
Case Report mucogingival junction in both the maxillary and mandibular
A 15-year-old female was referred to the Department of Periodon- arches. Gingival enlargement was Grade III (Bokenkamp et al.;
tics and Oral Implantology at Mahatma Gandhi Dental College 1994) in the maxillary and mandibular anterior sextant; the
and Hospital, Jaipur, Rajasthan, India, with a chief complaint of entire tissue was a bright fiery red, moderately thick and edem-
red swollen gums. It was associated with bleeding on slight provo- atous, with profuse bleeding on gentle manipulation (Figure
cation and pain when eating hard food. 1). The gingiva in the posterior region of both arches was rela-
The patient had neither relevant medical history nor any his- tively less edematous. The entire length of gingival tissue was
tory of mouth breathing. However, her oral hygiene history was easily reflectable, which exposed heavy plaque accumulation
significant, revealing a recent use of herbal toothpowder made around the teeth in the maxillary and mandibular anterior sex-
at home. The contents of this toothpowder were grounded black tants (Figure 2). Nikolskys sign was negative, with no blister
pepper, black salt, alum and ajwain. The patient had been rub- formation. The patient exhibited mild clinical attachment loss
bing the powder on her teeth and gums twice daily for the last six in relation to the maxillary and mandibular anterior sextant
months. There was associated gingival bleeding on slight provoca- and the maxillary first molars. Based upon the history and
Conclusion M.B. Mishra, M.D.S., is professor and head of the Department of Periodontics at Mahatma Gandhi
This case highlights the adverse effects and irrational use of herb- Dental College & Hospital, Jaipur, Rajasthan, India.
al agents in dentifrices. Plasma cell gingivitis is a diagnosis of
Swati Sharma, M.D.S., is senior lecturer, Department of Periodontics, Mahatma Gandhi Dental
exclusion, distinguished primarily by the histologic findings of a
College & Hospital, Jaipur, Rajasthan, India.
marked submucosal infiltrate, after excluding certain conditions.
It emphasizes the need for comprehensive history taking, Alok Sharma, M.D.S., is associate professor, Jaipur Dental College, Jaipur, Rajasthan, India.
careful clinical examination and appropriate diagnostic tests in
order to arrive at a definitive diagnosis and treatment plan for
gingival conditions that are refractory to conventional therapy
and exclude certain malignancies and oral manifestations of sys-
temic diseases. p
The authors report no potential conflict of interest relevant to this article. Queries
about this article can be sent to Swati Sharma at [email protected].